Fierce Pharma
DECEMBER 8, 2022
Merck escapes nearly 1,200 Zostavax shingles vaccine lawsuits as plaintiffs' testimony falls short. fkansteiner. Thu, 12/08/2022 - 09:22.
Pharmaceutical Technology
DECEMBER 8, 2022
Kite Pharma and Daiichi Sankyo have updated a partnership agreement signed in 2017 for the former’s CAR T-cell therapy, Yescarta (axicabtagene ciloleucel). Under the prior deal, Daiichi Sankyo acquired exclusive rights for the development, manufacturing and commercialisation of Yescarta in Japan. Subsequently, in the same year, Gilead Sciences acquired Kite.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
DECEMBER 8, 2022
Takeda's dengue shot scores crucial EU nod, opening the door to wider global use. zbecker. Thu, 12/08/2022 - 11:16.
PharmExec
DECEMBER 8, 2022
Our annual report spotlighting notable investments in new drug development captures a mix of gradual gains and giant leaps—both equally as promising—in five expanding and diverse therapeutic areas: spinal muscular atrophy, hemophilia A, intranasal and inhaled vaccines, gene-targeted therapy, and RNA therapeutics.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Fierce Pharma
DECEMBER 8, 2022
TherapeuticsMD lays off entire workforce after licensing products out for $153M. zbecker. Thu, 12/08/2022 - 15:35.
MedCity News
DECEMBER 8, 2022
The implications of a ubiquitous diet vital sign are enormous. For example, what can happen if we can measure an upstream variable—such as diet quality—across populations at scale? We can prevent disease, curb the onset of disease, save money, and help health systems improve their bottom lines.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
DECEMBER 8, 2022
Added complexity to daily life is likely why patient dropout rates remain high, with 19% leaving studies before completion. Truly patient-centric trials will allow for broader participation, allowing patients to decide how and when they want to engage in a study.
pharmaphorum
DECEMBER 8, 2022
Ramesh “Sunny” Balwani, the former business partner of Theranos founder Elizabeth Holmes, has been sentenced to nearly 13 years in prison after being convicted of wire fraud. His sentencing comes after ex-Theranos chief executive Holmes was given more than 11 years in prison last month after also being found guilty of defrauding investors in Theranos, which said it had developed technology that could diagnose a host of diseases with just a few drops of blood taken with a finger prick, rather tha
PharmExec
DECEMBER 8, 2022
Kimberly Moran, head of rare diseases in the US for UCB, started off working in medicine but quickly learned the importance of the business side of industry—and its role in helping improve the diagnosis and access paths for underserved patient segments.
MedCity News
DECEMBER 8, 2022
The Food as Medicine movement has received a lot of interest from payers and health systems recently. But employers need to get involved too, argues Dr. Bipin Mistry, chief medical officer of Alight.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
pharmaphorum
DECEMBER 8, 2022
Just as the life sciences industry is getting vocal about how it’s faring, given the prospect of having to pay back the government 30% of NHS branded medicines sales in 2023, and as it needs to negotiate a new deal on branded medicines pricing and access that will apply from 2024 onwards – there’s been more talk about the Life Sciences Council (LSC).
MedCity News
DECEMBER 8, 2022
The volume of healthcare deals has increased in 2022, driven in large part by private equity, according to a new PwC report. But deal values have been declining, a trend that is expected to continue into 2023.
Pharmaceutical Commerce
DECEMBER 8, 2022
Stakeholders are investing heavily in their ability to curate appropriate data sets and devise advanced data-analytics capabilities to harness real-world evidence (RWE) across the entire pharma lifecycle—from drug discovery and development through product launch and commercialization.
MedCity News
DECEMBER 8, 2022
The White House launched a new initiative to address the country’s opioid crisis — a dashboard tracking non-fatal opioid overdoses. The new tool is meant to track overdose clusters to inform better medical responses and preparedness.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Pharmaceutical Technology
DECEMBER 8, 2022
The US Food and Drug Administration (FDA) has granted an amendment to the Emergency Use Authorization (EUA) for Pfi z er and BioNTech’s Omicron BA.4/BA.5-adapted bivalent Covid-19 vaccine for usage in children aged six months to four years. The vaccine is indicated for use as a third 3µg dose in the three-dose initial regimen for children of this age group.
MedCity News
DECEMBER 8, 2022
Through the partnership, the organizations are launching EmsanaRx Plus. The product supplements employers’ current pharmacy benefit offerings and provides access to Cost Plus Drugs’ discounted medications.
pharmaphorum
DECEMBER 8, 2022
Flying into London recently for the Jefferies Conference, Novavax’s EVP, chief commercial officer, and chief business officer John Trizzino, together with the company’s chief medical officer Filip Dubovsky, took time out of very packed schedules indeed to speak with pharmaphorum Web editor Nicole Raleigh in a small (though not always necessarily quiet) corner of the One Aldwych Hotel on the Strand.
Tribeca Knowledge
DECEMBER 8, 2022
T he pharmaceutical industry has little room for complacency in a post-COVID world. As we map out in our pharma trends for 2023, COVID-related disruption has created a whole new set of launch readiness and market access challenges for companies looking to maximise their assets in the new year.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
PharmaVoice
DECEMBER 8, 2022
The company with three marketed RNA drugs for Duchenne muscular dystrophy is taking the logical leap into gene therapies with a candidate under review at the FDA.
Pharma Pathway
DECEMBER 8, 2022
Sun Pharma-Walk-In Interviews for Multiple Openings in Production / Packing Operator On 11th Dec’ 2022. Job Description. Walk-In Interviews for Production/ Packing Departments @ Sun Pharma. Department: Production Operator/ Packing Operator-Formulation. Education: B.Sc/ ITI/ Diploma. Experience: 02 to 05 years. Position: Technician. Job Location: Dewas.
Pharmaceutical Commerce
DECEMBER 8, 2022
How biopharma commercial teams can leverage machine learning techniques to improve targeting of HCPs and patients.
Pharma Pathway
DECEMBER 8, 2022
AMN Life Science Pvt. Ltd-Walk-In Interview for Quality Assurance/ Quality Control/ ADL/ F&D On 11th Dec’ 2022. Job Description. Walk-In Interview for Quality Assurance/ Quality Control/ ADL/ F&D On 11th Dec’ 2022 @ AMN Life Science Pvt. Ltd. Departments: Quality Assurance/ Quality Control/ ADL/ F&D. Designation: Officer/ Sr.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Copyright Clearance Center
DECEMBER 8, 2022
The post Some Observations from Charleston (Open Access Edition) appeared first on Copyright Clearance Center.
Pharma Pathway
DECEMBER 8, 2022
Micro Labs-Walk-In Interview for Quality Control Department On 10th Dec’ 2022. Job Description. Greetings from Micro Labs, Walk-In Interview for Quality Control Department On 10th Dec’ 2022 @ Micro Labs. Department: Quality Control. Qualification: M.Sc/ B.Pharm/ M.Pharm. Experience: 02 to 09 years. Job Location: Hosur. Date of Interview: 10th Dec’ 2022.
PharmExec
DECEMBER 8, 2022
Companies should search within to gain talent edge.
Pharma Pathway
DECEMBER 8, 2022
Macleods Pharmaceuticals Limited- Walk-In Interviews for Production/ QA/ QC On 16th Dec’ 2022. Job Description. Macleods Pharmaceuticals Ltd is Hiring ! Walk-In Drive at Indore for Baddi & Sikkim Location. Walk-In Interviews for Production/ Quality Control/ Quality Assurance @ Macleods Pharmaceuticals Limited. Departments: Production/ Quality Control/ Quality Assurance.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
PharmaTimes
DECEMBER 8, 2022
Implantable ARC therapy demonstrates potential to improve blood pressure regulation
Pharma Pathway
DECEMBER 8, 2022
Hetero Labs Limited-Walk-In Interviews for Production/ Packing/ QC Departments On 10th Dec’ 2022. Job Description. Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Hetero’s business includes APIs, generic, biosimilars, custom pharmaceutical services, and branded generics.
MedCity News
DECEMBER 8, 2022
Read about executive hires across healthcare and life sciences.
Pharma Pathway
DECEMBER 8, 2022
Granules India Limited- Walk-In Drive for Granulation/ Compression/ Coating/ Capsule Filling/ QC/ Warehouse/ IPQA On 10th Dec’ 2022. Job Description. Company Profile: Granules India Limited is an Indian pharmaceutical manufacturing company based in Hyderabad, Indian. Granules manufacturing several off-patent drugs, including Paracetamol, Ibuprofen, Metformin and Guaifenesin, on a large scale for customers in the regulated and rest of the world markets.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
222 
Let's personalize your content